Navigation Links
Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
Date:2/26/2008

athway - minimizes the effect of the cancer's local immunosuppressive defenses.

About Non-Small Cell Lung Cancer (NSCLC)

In the United States, lung cancer is the second most frequent cancer in both men (next to prostate cancer) and women (next to breast cancer). It remains the major cause of cancer death, killing more people than breast cancer, prostate cancer and colorectal cancer combined, and accounting for almost 30% of all cancer-related deaths.

NSCLC accounts for approximately 80% of all new lung cancer cases, with approximately 150,000 patients in the United States and 300,000 patients in Europe diagnosed each year. Most patients diagnosed with NSCLC have late- stage disease (Stage IIIB or IV), which is not surgically resectable. The current U.S. standard of care for these patients is systemic chemotherapy. Even with the available therapy, the five-year survival rate for these patients is less than 3%.

About Agennix

Agennix is a private biotechnology company developing a first-in-class molecule with activity in several types of cancer and in other indications with unmet medical needs. This molecule, talactoferrin, is a targeted dendritic cell activator with a novel mechanism of action. Agennix is preparing to initiate Phase 3 trials in two NSCLC indications (talactoferrin in combination with chemotherapy in previously untreated patients and talactoferrin monotherapy in patients who have failed two or more previous therapies), a Phase 2b trial in renal cell cancer, and Phase 2 trials in other indications. Talactoferrin's potential advantages in NSCLC and in other tumor types include its promising anti-tumor activity, its well tolerated safety profile including a reduction of some chemotherapy toxicities, its oral route of administration, and its apparent usefulness in multiple tumor types both as a single agent and in combination with other drugs. Agennix retains all of the commercial and economic rights to talactoferrin for
'/>"/>

SOURCE Agennix
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
2. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
3. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
4. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
5. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
6. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
7. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
8. Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior
9. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
10. Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
11. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage ... regeneration, today announced that J.J. Finkelstein , chief ... corporate overview at two upcoming investor conferences. ... th Annual Microcap Conference on Thursday May 28, ... at 11:00 am EDT.  A webcast will be available ...
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... of the results of the Company,s 72-patient, placebo-controlled ... drops) for the treatment of dry eye patients ... ) model.  The exploratory study was completed in ... disseminated by the Company in a press release, ...
(Date:5/22/2015)... May 20, 2015 Research and Markets( ... "Guide to Prepare Application Dossiers for Oversea ... Edition) " report to their offering. ... of segment market of the most growth potentiality, ... device manufacturers and producers to penetrate such market. ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
... Device Designed for Type-2 Diabetes Patients Who Are Overweight ... to Current Oral Anti-Diabetic Treatments Device ... NEW YORK, March 28 New York-Presbyterian Hospital/Weill,Cornell Medical ... of an investigational implantable device designed to help,those with ...
... Preclinical Data Indicates MSI-1436 Does Not Alter Rate of Dopamine ... ... 28 Genaera,Corporation (Nasdaq: GENR ) announced that preclinical data was ... Roitman, Ph.D., a Genaera collaborator and investigator with the,University of Illinois at ...
Cached Medicine Technology:New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients 2Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting 2Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting 3Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting 4
(Date:5/22/2015)... May 22, 2015 Memorial Day weekend is ... Insurance is offering some tips to help promote safe ... there will be 383 traffic fatalities this Memorial Day weekend. ... National Highway Traffic Safety Association: , , ... vehicle is wearing a seatbelt, whether they’re driving or riding ...
(Date:5/22/2015)... MOUNTAIN VIEW, California (PRWEB) May 22, 2015 ... Breakers, has set a RecordSetter.com World Record at the 104th ... Coco Libre coconut water ice luge served 315 people in ... Zappos.com Bay to Breakers race is so true to the ... that we felt bringing an ice luge to the finish ...
(Date:5/22/2015)... 22, 2015 The dentist ... announces that they are now offering complimentary consultations ... dental treatments. At consultations, patients can discuss their ... what certain treatments can achieve and whether alternative ... this initial appointment. If treatments are chosen, patients ...
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the ... now the 16th sweetFrog store located in the Lone Star ... on the Inc. 500 list of fastest growing companies in ... East Texas for 20 years and love the natural beauty ... and nearby Palestine, sweetFrog locations. “We are really excited about ...
(Date:5/22/2015)... May 22, 2015 DMG Productions announces ... scheduled to broadcast on Friday, May 29, 2015 at ... Channel. , In this episode Innovations will explore Interstate ... to business quickly through disaster recovery and restoration. , ... that works collaboratively to develop and deliver training and ...
Breaking Medicine News(10 mins):Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2
... GORDONSVILLE, Va., May 28 PBM Holdings, Inc., ... announced today that,its Chinese affiliate company, PBM (Guangzhou) ... of the China earthquake. PBM is,partnering with the ... Red,Cross, an affiliate of the Red Cross Society ...
... in helping ... and stay on therapy, DENVER, May 28 Nearly all ... their commitment to,managing their disease in every way possible is their ... survey of people with,MS, results of which were released today at ...
... Study estimates savings of more than $60 million over 11 ... use of air bags and seat belts significantly reduces injuries ... crash and also lowers in-hospital death rates, injury severity and ... , It also suggests that optimal use of air bags ...
... published in the May 2008 (volume 8, issue 25) ... (pic-noj-en-all), an antioxidant plant extract from the bark of ... type II diabetes patients, allows people to lower ... factors. The study, conducted at the University of Arizona, ...
... The old,saying, "beauty is in the eye ... study in a recent issue of Plastic and ... Society of Plastic,Surgeons (ASPS), found that variations in ... your facial expressions, and,subsequent mood, are perceived by ...
... China Sky One,Medical, Inc. (Amex: CSY ) ... and distributor of pharmaceutical, medicinal and,diagnostic products in ... Public Accountants and Advisors LLP (,Moore Stephens,) as ... terminated its,contract with Sherb & Co., LLP that ...
Cached Medicine News:Health News:PBM Companies Partner with the Red Cross to Donate Infant Formula to China Earthquake Victims 2Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 2Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 3Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 4Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 5Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 6Health News:Air Bags-Seat Belts Cut Injuries, Deaths, Costs 2Health News:Study shows pine bark naturally reduces cardiovascular risk factors in diabetics 2Health News:Study shows pine bark naturally reduces cardiovascular risk factors in diabetics 3Health News:Looking Tired or Angry May Have More to do With Facial Aesthetics Than How You Feel, ASPS Study Reveals 2Health News:Looking Tired or Angry May Have More to do With Facial Aesthetics Than How You Feel, ASPS Study Reveals 3Health News:China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor 2Health News:China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor 3
Provides a combination of concentrated cold / hot and compression for the knee...
Provides a combination of concentrated cold / hot and compression for the wrist...
Provides compression, support, immobilization for the knee in addition to cold / hot therapy...
... One-Piece™ Collar is completely injected molded from ... our patented chin support. , ,Our ... efficiently managed where space is limited. Color-coded ... of sizes., ,Either in a supine ...
Medicine Products: